Fig. 5From: Preparation of a camptothecin analog FLQY2 self-micelle solid dispersion with improved solubility and bioavailabilityA Plasma FLQY2 concentration–time curve following oral administration of 8 mg/kg FLQY2 in different formulations. B Tissue distribution. C Accumulation and excretion in feces and urine after oral administration of 4 mg/kg FLQY2-SDBack to article page